Last year Insulet Corporation announced that it would be establishing direct operations for its Omnipod System across Europe. That means that the company will be taking over the distribution, sales, marketing, training and support for the Omnipod System across Europe once its read more »

In this article I  look at some of the clinical trials being undertaken in what is being refer to as a ‘bionic’ or ‘artificial’ pancreas (AP), also known as close-loop insulin delivery. It is an overview and therefore not entirely comprehensive. As read more »